Finland· FI-REL-REL62604
Datroway
A datopotamab deruxtecan product containing datopotamab deruxtecan, registered in Finland by Daiichi Sankyo Europe GmbH. The same ATC class is registered in 9 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Datopotamab deruxtecan is registered in 9 of 19 countries.
Countries holding a registration under ATC L01FX35 (datopotamab deruxtecan), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Datopotamab deruxtecan · ATC L01FX35
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Switzerlandprice
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Datopotamab deruxtecan
- Manufacturer
- Daiichi Sankyo Europe GmbH
- Country
- Finland (FI)
- ATC code
- L01FX35
- ATC class
- Datopotamab deruxtecan
- Defined daily dose
- 20 mg, P
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Datopotamab deruxtecan in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumDatroway 100 mgDaiichi Sankyo Europe
- SwitzerlandDATROWAY 100 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungDaiichi Sankyo (Schweiz) AG
- CzechiaDATROWAYDaiichi Sankyo Europe GmbH, Mnichov
- SpainDATROWAY 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONDaiichi Sankyo Europe Gmbh
- IrelandDatroway 100 mg powder for concentrate for solution for infusionDaiichi Sankyo Europe GmbH
- IcelandDatrowayDAIICHI SANKYO EUROPE GmbH*
- PolandDatrowayDaiichi Sankyo Europe GmbH
- SwedenDatroway 100 mg Pulver till koncentrat till infusionsvätska, lösningDaiichi Sankyo Europe GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Datroway
- Liechtenstein · Datroway
- Norway · Datroway
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/59897fc6-dccf-4a17-8d86-c38240dde2af GET /v1/drugs/59897fc6-dccf-4a17-8d86-c38240dde2af?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "kuiva-aine välikonsentraatiksi infuusionestettä varten, liuos",
"route": "Laskimoon",
"ddd_unit": null,
"strength": "100 mg",
"atc_label": "datopotamabi-derukstekaani",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/25/1915/001",
"fimea_rel_id": "REL62604",
"authorised_at": "2025-04-04"
}See everything about datopotamab deruxtecan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.